Israel Chemicals Ltd. (NYSE:ICL)’s earnings release is awaited by WallStreet on May, 9, Faxor reports. The earnings per share diference is $0.02 or 25.00 % up from last years number. Previous year: $0.08; Analysts forcast: $0.10. ICL’s profit could hit $126.91M with 13.35 P/E in case $0.10 earnings per share is published. After $0.10 earnings per share was published previous quarter, analysts now see EPS growth of 0.00 % for Israel Chemicals Ltd.. Ticker’s shares touched $5.34 during the last trading session after 0.95% change.Israel Chemicals Ltd. has volume of 88,283 shares. Since April 14, 2018 ICL has risen 32.24% and is uptrending. ICL outperformed by 27.87% the S&P500.
Israel Chemicals Ltd. operates as a specialty minerals firm worldwide.The company has $6.78 billion market cap. The firm operates through two divisions, Essential Minerals and Specialty Solutions.5.51 is the P/E ratio. The firm extracts potash from the Dead Sea; mines and produces potash and salt from subterranean mines in Spain and the United Kingdom, as well as uses part of the potash to produce compound fertilizers; mines and processes phosphate rock in open mines; and produces sulfuric acid, agricultural phosphoric acid, phosphate fertilizers, compound fertilizers, liquid fertilizers, and soluble fertilizers.
For more Israel Chemicals Ltd. (NYSE:ICL) news released briefly go to: Nasdaq.com, Seekingalpha.com, Seekingalpha.com, Prnewswire.com or . The titles are as follows: “DowDuPont Wraps Up Separation of Materials Science Division – Nasdaq” released on April 02, 2019, “Israel Chemical +5% on “exceeded management’s expectations” – Seeking Alpha” on August 01, 2018, “An Analysis On Israel Chemicals Ltd. – Seeking Alpha” with a publish date: June 21, 2017, “Israel Corp. Reports Results for Fourth Quarter of 2018 – PRNewswire” and the last “ICL vs. ECL: Which Stock Should Value Investors Buy Now? – Yahoo Finance” with publication date: February 22, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.